ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1636

Age-associated B Cells Contribute to Inflammation of Takayasu’s Arteritis in an Antibody-secreting Cell Differentiation Independent Manner

Chenglong Fang1, Xiaochuan Sun2, Shangyi Jin2, Lihong du2, Jing Li2, Xiaofeng Zeng3, Yuexin Chen4, Mengtao Li5 and Xinping Tian3, 1Department of Rheumatology, Second Affiliated Hospital of Fujian Medical University, Quanzhou, China (People's Republic), 2Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Beijing, China, 3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 4Department of Vascular Surgery, Peking Union Medical College Hospital, Beijing, China, 5Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China

Meeting: ACR Convergence 2024

Keywords: Aging, B-Lymphocyte, immunology, Takayasu.s arteritis, Vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 17, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Although Takayasu’s arteritis (TAK) is not a prototypical autoantibody-mediated autoimmune disease, several lines of evidence suggested the pathogenic potential of B cells. However, limited data on the pathway of B cell activation and its underlying pathogenic role in TAK was reported.

Methods: Histology of paravascular lymph nodes from patients with TAK was studied. Bulk RNA-Seq, single-cell RNA-seq (scRNA-Seq) and flow cytometry were conducted to investigate the transcriptomic features and compositional characterizations of circulating B cells in TAK. The phenotype and function of age-associated B cells (ABCs) were elucidated by scRNA‐seq analysis, scATAC-seq analysis, flow cytometry, and in vitro experiments. The numeric and phenotypic changes of ABCs induced by pharmacological intervention were revealed by in vitro study and follow-up in patients with TAK.

Results: Histological findings of paravascular lymph nodes suggested seriously disordered germinal center (GC), disrupted T- and B-cell zones, and marked reduction of germinal center type follicular T helper cells (GC-TFH) and GC B cells (GCB) (Figure 1). Upregulation of inflammation-linked pathways that were associated with extrafollicular (EF) response in circulating B cells from patients with TAK was revealed by bulk transcriptomic analysis (Figure 1). Flow cytometry showed the significantly increased proportions of circulating ABCs in TAK. Although the proportions of circulating ABCs did not correlate with disease activity, the association between ABCs and disease relapse was observed (Figure 1). Functionally, RNA velocity and Slingshot pseudotime analysis indicated that ABCs of patients with TAK had a completely different trajectory of differentiation from that towards antibody-secreting cells (ASCs). In contrast, ABCs exhibited distinct proinflammatory capability by intrinsically increasing inflammatory cytokines production and promoting Th17 response in TAK (Figure 2). Therapeutically, ABCs of patients with TAK have the property of glucocorticoid resistance mediated by ATP-binding cassette subfamily B member 1 (ABCB1). Upregulated STAT1 phosphorylation at Tyr701 and STAT3 phosphorylation at Ser727 were detected in ABCs of TAK, compared with non-ABC B cells counterpart. Transcription factor (TF) analysis and motif analysis showed that STAT1 was a critical TF in ABCs of TAK. In vitro experiments and clinical observation suggested that JAK inhibition led to both quantitative reduction and reversal of proinflammatory phenotype of ABCs in TAK (Figure 3).

Conclusion: Enhanced EF response and ABCs production are two prominent features of humoral immunity dysfunction in TAK. ABCs may contribute to the pathogenesis of TAK via the proinflammatory phenotype in distinct manners independent of ASCs differentiation. JAK inhibition is a promising therapy that suppresses ABCs in TAK.

Supporting image 1

Figure 1 Disordered germinal center in paravascular lymph nodes and enhanced age-associated B cells (ABCs) production in patients with Takayasu’s arteritis (TAK)

Supporting image 2

Figure 2 ABCs contribute to inflammatory mechanisms of TAK in a manner independent of antibody-secreting cell differentiation

Supporting image 3

Figure 3 ABCs of patients with TAK have the property of glucocorticoid resistance imparted by ATP-binding cassette subfamily B member 1 (ABCB1) and respond to tofacitinib treatment


Disclosures: C. Fang: None; X. Sun: None; S. Jin: None; L. du: None; J. Li: None; X. Zeng: None; Y. Chen: None; M. Li: None; X. Tian: None.

To cite this abstract in AMA style:

Fang C, Sun X, Jin S, du L, Li J, Zeng X, Chen Y, Li M, Tian X. Age-associated B Cells Contribute to Inflammation of Takayasu’s Arteritis in an Antibody-secreting Cell Differentiation Independent Manner [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/age-associated-b-cells-contribute-to-inflammation-of-takayasus-arteritis-in-an-antibody-secreting-cell-differentiation-independent-manner/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-associated-b-cells-contribute-to-inflammation-of-takayasus-arteritis-in-an-antibody-secreting-cell-differentiation-independent-manner/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology